Compare Boston Scientific Corporation (BSX) vs Vanguard S&P 500 ETF (VOO) Price & Performance

Boston Scientific CorporationTrade

Vanguard S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs Vanguard S&P 500 ETF — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while Vanguard S&P 500 ETF trades at $710.06. The key difference: Vanguard S&P 500 ETF is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.

	BSX	VOO
Market Cap	$74.19B	—
Sector	Health	Broad Market / Factor
52-Week High	$108.14	$710.71
52-Week Low	$42.63	$580.93
Enterprise Value	$86.27B	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boston Scientific Corporation

No Aura AI signal available yet.

Vanguard S&P 500 ETF

VOO (Vanguard S&P 500 ETF) trades at $710.71, up 0.6% with a bullish technical signal from moving averages. The ETF tracks the S&P 500 index, which recently reclaimed record highs amid strong corporate earnings and AI-driven optimism. Technical indicators show overbought conditions with RSI at 94.45 on the 6-day timeframe, while support levels begin at $708. JPMorgan raised its S&P 500 year-end target to 8,000, citing earnings strength and AI investment payoffs.

The outlook remains positive given robust earnings growth and institutional confidence, though near-term consolidation risks exist from overbought technicals and valuation concerns. Key risks include market breadth weakness and potential September volatility. The ETF's low-cost structure and diversification continue to attract long-term investors seeking S&P 500 exposure.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BSX

Boston Scientific posts strong Q2 growth despite U.S. challenges, stock now valued attractively.Seeking Alpha · 1 day agoBullish Boston Scientific to present at Wells Fargo Healthcare Conference and report Q3 2026 results in OctoberPRNewsWire · 2 days agoNeutral View details →

VOO

Fidelity's zero-fee fund challenges Vanguard's S&P 500 ETF but offers limited gains for taxable accounts.24/7 Wall Street · 1 day agoNeutral Vanguard High Dividend Yield ETF lags S&P 500 by $141K over 10 years despite dividends.24/7 Wall Street · 1 day agoBearish Vanguard's S&P 500 ETF (VOO) offers cheaper, more flexible access than the mutual fund VFIAX.24/7 Wall Street · 2 days agoBullish View details →

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About Vanguard S&P 500 ETF

VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.